Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
MET amplification identified as a potentially actionable driver for non-small cell lung cancer

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

Study highlights the impact of structural racism and residential segregation on lung cancer outcomes

Study highlights the impact of structural racism and residential segregation on lung cancer outcomes

PET/CT images can be used to measure biomarker levels, predict lung cancer outcomes

PET/CT images can be used to measure biomarker levels, predict lung cancer outcomes

Study uncovers novel drug that effectively thwarts pancreatic tumors

Study uncovers novel drug that effectively thwarts pancreatic tumors

Study: Lung squamous patients harboring druggable mutations have lower median overall survival

Study: Lung squamous patients harboring druggable mutations have lower median overall survival

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

FDA approves targeted therapy for tumors with KRAS mutations

FDA approves targeted therapy for tumors with KRAS mutations

FDA approves Rybrevant for treating subset of non-small cell lung cancer

FDA approves Rybrevant for treating subset of non-small cell lung cancer

New approach combines molecular and medical imaging data to diagnose cancer type

New approach combines molecular and medical imaging data to diagnose cancer type

Study identifies novel combination therapy to help patients with advanced lung cancer

Study identifies novel combination therapy to help patients with advanced lung cancer

New genetic markers may lead to personalized treatments for lung cancer

New genetic markers may lead to personalized treatments for lung cancer

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

High expression of cell death genes may increase risk of early death from lung cancer

High expression of cell death genes may increase risk of early death from lung cancer

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

NCCN Annual Conference discusses new ways to improve cancer care

NCCN Annual Conference discusses new ways to improve cancer care

Novel method can improve the detection of circulating tumor cells

Novel method can improve the detection of circulating tumor cells

Newly identified biomarker could predict response to immune checkpoint inhibitors

Newly identified biomarker could predict response to immune checkpoint inhibitors

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Researchers use cachexia model to assess cancer-derived myocardial impairments

Researchers use cachexia model to assess cancer-derived myocardial impairments